Mark Gabriel Lebwohl
- Medicare services, 2022
- 488
- Part D claims, 2024
- 838
- Publications
- 666
- Clinical trials
- 21
- Hospital affiliations
- 4
- Practice address
- 4300 Alton Rd, Miami Beach, FL 33140
- Practice phone
- Call (305) 674-2121
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Mark Lebwohl's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Mark Gabriel Lebwohl is a dermatologist in New York, New York
Mark Lebwohl practices at Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida.
Mark Lebwohl's NPI, 1013902444, was assigned on September 12, 2005. Mark Lebwohl graduated from Harvard Medical School in 1978. Mark Lebwohl holds New York license 141913.
- NPI
- 1013902444NPI Registry (opens in a new tab)
- NPI enumeration date
- September 12, 2005
- NPI status
- Active
- Practice phone
- (305) 674-2121
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 74
- Medical school graduation
- 1978
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Mark Gabriel Lebwohl practices in Miami Beach and New York
Mark Lebwohl's primary practice is Mount Sinai Medical Center, at 4300 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 674-2121. Mark Lebwohl also practices at Mount Sinai Medical Center, 5 E 98th St, New York, NY 10029.
- Mount Sinai Medical CenterPrimary4300 Alton Rd, Miami Beach, FL 33140 · Miami-Dade CountyPhone(305) 674-2121
- Mount Sinai Medical Center5 E 98th St, New York, NY 10029 · New York CountyPhone(310) 227-5687
Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; and Dmand AI Practice Data
Mark Gabriel Lebwohl is affiliated with 4 sites of care
Mark Lebwohl's primary practice is Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida. Mark Lebwohl is also affiliated with The Mount Sinai Hospital. Dmand AI also links Mark Lebwohl to 2 more hospitals, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Mark Gabriel Lebwohl's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Mark Lebwohl practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Mount Sinai Medical Center | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Mount Sinai Medical Center of Florida and 6.2K+ hospitals, with verified contacts in the same login.
Mark Gabriel Lebwohl is one of 1,038 dermatologists in New York
Dermatology is Mark Lebwohl's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Mark Lebwohl is board certified in dermatology by the American Board of Dermatology. Mark Lebwohl is licensed in New York.
Specialties and state licenses
- Dermatology, New YorkPrimary
Dermatologists near Mark Lebwohl
Counts of dermatologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Mark Gabriel Lebwohl billed Medicare for 488 services in 2022
CMS data shows 488 Medicare services from Mark Lebwohl across 8 procedure codes in 2022. Medicare paid $30,918 for them. Every service was in an office.
Mark Lebwohl's Medicare services by type, 2021 to 2022
- 2021
- 2022
- Office and hospital visits
- 2021: 1,5722022: 28782%
- Surgery
- 2021: 9462022: 20179%
- Drugs given in the office
- 2021: 3,4072022: 0100%
- Tests and treatments
- 2021: 492022: 0100%
Mark Lebwohl compared with the New York median for dermatologists, 2022
- Mark Lebwohl
- New York median
- Medicare services
- 488vs 1,01652% below
- Part D claims
- 611vs 33483% above
Medians across 1,022 dermatologists in New York with Dmand AI profiles that report each measure.
Mark Lebwohl's most billed Medicare procedure codes, 2022
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Mark Lebwohl?
Medicare shows one payer. Book a meeting to get commercial claims data for Mark Lebwohl and other dermatologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Mark Gabriel Lebwohl's patients have a median age of 56
Across all payers, Dmand AI patient panel data puts Mark Lebwohl's median patient age at 56, with 45% women.
Mark Lebwohl's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 56
Patient panel by sex, all payers
- Women45%
- Men51%
Source: Dmand AI Patient Panel Data
Mark Gabriel Lebwohl wrote 838 Medicare Part D claims in 2024
In 2024, Mark Lebwohl wrote 838 Medicare Part D claims for 268 patients. 80% of them were for generic drugs. CMS names the drug for 611 of them, across 23 drugs with 11 or more claims each, at $351,586 in total drug cost. In 2023, CMS named 700 claims across 21 drugs.
Mark Lebwohl's Part D claims by kind of drug, 2024
- Generic669 claims80%
- Brand-name and other169 claims20%
Mark Lebwohl's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Mark Lebwohl's Part D claims, 2024
- Antibiotics3%28 of 838 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 7002024: 61113%
Drugs named by CMS: 23 in 2024, 21 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Mark Gabriel Lebwohl has 666 publications on record
Dmand AI links 666 papers to Mark Lebwohl, published from 2002 to 2025. 2020 was the busiest year, with 33. The most frequent topics are Psoriasis, Dermatologic Agents and Double-Blind Method. Mark Lebwohl has published most often in J Am Acad Dermatol. Mark Lebwohl's most frequent co-authors are Bruce E. Strober, MD, Andrew Blauvelt, MD and Linda F. Stein Gold, MD.
Mark Lebwohl's papers by year, 2016 to 2025
Topics Mark Lebwohl writes about most
- Psoriasis
- Dermatologic Agents
- Double-Blind Method
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal
- Skin
- Administration, Cutaneous
- Administration, Topical
Mark Lebwohl's most frequent co-authors
- Bruce E. Strober, MD40 shared papers
- Andrew Blauvelt, MD39 shared papers
- Linda F. Stein Gold, MD24 shared papers
Recent publications by Mark Lebwohl
See who Mark Lebwohl researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Mark Lebwohl works with, so you can find a warm path to the right dermatologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Mark Gabriel Lebwohl has worked on 21 clinical trials
Dmand AI links Mark Lebwohl to 21 clinical trials, 8 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Psoriasis, Skin Diseases, Papulosquamous and Keratosis, Actinic. Icahn School of Medicine at Mount Sinai sponsors the most, 7. Open Payments lists research payments to Mark Lebwohl that name 5 trials.
Clinical trials with Mark Lebwohl by phase
- 3Phase 1: 3 trials
- 8Phase 2: 8 trials
- 2Phase 3: 2 trials
- 2Phase 4: 2 trials
Conditions in Mark Lebwohl's trials
- Psoriasis
- Skin Diseases, Papulosquamous
- Keratosis, Actinic
- Alopecia Areata
- Facies
Investigators on the most trials with Mark Lebwohl
- Craig L. Leonardi, MD4 shared trials
- Jeffrey Michael Sobell, MD4 shared trials
- Ira Hughes Thorla, MD4 shared trials
Recent clinical trials with Mark Lebwohl
An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata (opens in a new tab)
Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study (opens in a new tab)
Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Mark Gabriel Lebwohl received $899,265 in industry payments from 2016 to 2025
CMS Open Payments shows 1,594 general payments to Mark Lebwohl from 52 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Pfizer Inc. paid the most, $113,034. It also lists 164 research payments totaling $1,311,361 from 2016 to 2025, naming 5 clinical trials.
General payments to Mark Lebwohl by program year, 2016 to 2025
General payments to Mark Lebwohl by kind, 2016 to 2025
- Consulting fees$518,30758%
- Speaker and faculty fees$170,01719%
- Travel and lodging$107,28312%
- Food and beverage$39,5244%
- Other$64,1347%
Companies that paid Mark Lebwohl the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Mark Gabriel Lebwohl has 5 awards and honors on record
Dmand AI lists 5 awards for Mark Lebwohl, most recently Gold Medal in 2022.
Awards and honors for Mark Lebwohl
- 2022
- Gold Medal
- Undated
- AAD Fellow
- Checkbook Top Doc
- Super Doc
- Whos Who
Source: Dmand AI Professional Profile Data
Mark Gabriel Lebwohl graduated from Harvard Medical School
Mark Lebwohl graduated from Harvard Medical School in 1978. Mark Lebwohl is a member of AAD.
- Medical school
- Board certified in dermatology
- Board certified in internal medicine
Source: Dmand AI Professional Profile Data
Mark Gabriel Lebwohl accepts plans from 1 insurance carrier
Mark Lebwohl is in network with 1 carrier, including Excellus BlueCross BlueShield. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
- Excellus BlueCross BlueShield
Plan types Mark Lebwohl accepts, by number of carriers
- EPO1
- HMO1
- Medicare1
- POS1
- PPO1
Source: Dmand AI Insurance Network Data
Sources for Mark Gabriel Lebwohl's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDmand AI Practice Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Mark Gabriel Lebwohl
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Mark Gabriel Lebwohl's NPI number?
Mark Gabriel Lebwohl's NPI number is 1013902444. It was assigned on September 12, 2005, and it is active in the NPI Registry.
What does Mark Gabriel Lebwohl specialize in?
Mark Gabriel Lebwohl is a dermatologist in New York, New York. The primary specialty in the NPI Registry is Dermatology Physician (taxonomy code 207N00000X).
Where does Mark Gabriel Lebwohl practice?
Mark Lebwohl practices at 4300 Alton Rd, Miami Beach, FL 33140. Mark Lebwohl also practices at 5 E 98th St, New York, NY 10029. Mark Lebwohl's primary practice is Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida. Dmand AI also links Mark Lebwohl to 2 hospitals.
What is Mark Gabriel Lebwohl's office phone number?
The practice phone on file for Mark Lebwohl is (305) 674-2121.
What is Mark Gabriel Lebwohl's medical license number?
Mark Lebwohl holds New York license 141913.
Which hospitals is Mark Gabriel Lebwohl affiliated with?
Mark Lebwohl practices at Mount Sinai Medical Center in Miami Beach, Florida. Mark Lebwohl is also affiliated with The Mount Sinai Hospital. Dmand AI links Mark Lebwohl to 2 more hospitals.
Does Mark Gabriel Lebwohl accept Medicare?
Yes. CMS data shows Mark Lebwohl billed Medicare for 488 services in 2022.
Is Mark Gabriel Lebwohl board certified?
Yes. Mark Lebwohl is board certified in dermatology by the American Board of Dermatology.
What services does Mark Gabriel Lebwohl bill to Medicare?
In 2022, Mark Lebwohl's most billed Medicare services were office visit, established patient (99214), surgery: skin and soft tissue (17003) and surgery: skin and soft tissue (11102).
Where did Mark Gabriel Lebwohl go to medical school?
Mark Lebwohl graduated from Harvard Medical School in 1978.
Show 6 more questionsShow fewer questions
What drugs does Mark Gabriel Lebwohl prescribe most?
In 2024 Medicare Part D data, Mark Lebwohl's most prescribed drugs by claims were Mometasone Furoate, Clobetasol Propionate and Mupirocin.
Has Mark Gabriel Lebwohl received payments from drug or device companies?
CMS Open Payments shows $899,265 in general payments to Mark Lebwohl from 52 companies from 2016 to 2025. The largest total came from Pfizer Inc.
How long has Mark Gabriel Lebwohl been practicing?
Mark Lebwohl graduated from medical school in 1978, 48 years ago.
Does Mark Gabriel Lebwohl do research?
Dmand AI links 666 publications to Mark Lebwohl, published from 2002 to 2025. Mark Lebwohl has worked on 21 clinical trials.
Who does Mark Gabriel Lebwohl publish with?
Mark Lebwohl's most frequent co-authors are Bruce E. Strober, MD (40 shared papers), Andrew Blauvelt, MD (39 shared papers) and Linda F. Stein Gold, MD (24 shared papers).
What insurance does Mark Gabriel Lebwohl accept?
Mark Lebwohl is in network with 1 carrier, including Excellus BlueCross BlueShield. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
Selling to dermatology practices?
See dermatologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card